title: Submicromolar La3+ concentrations block the calcium release-activated channel, and impair CD69 and CD25 expression in CD3- or thapsigargin-activated Jurkat cells.
abstract: The calcium release-activated channel (CRAC) opened in Jurkat cells activated either with CD3 monoclonal antibody or the endoplasmic reticulum Ca2(+)-ATPase blocker, thapsigargin, is blocked by La3+ with an IC50 of 20 nM. Similarly, the entry of Mn2+, used as a surrogate for Ca2+, is also blocked by submicromolar La3+ concentrations. La3+ seems to play its role simply by plugging the CRAC because this ion does not penetrate the cells, as demonstrated by chelation experiments with EGTA. Blocking the Ca2+ influx in activated Jurkat cells results in a lack of expression of CD25, a chain of the interleukin-2 receptor and of CD69, a marker of T-cell activation. By contrast, the very early steps of the T-cell signalling pathway such as the release of Ca2+ from intracellular stores and the subsequent inhibition of phosphatidylserine synthesis are not affected by La3+.
authors.affiliation: INSERM U343, Hôpital de l'Archet, Nice, France.
authors.forename: C
authors.initials: C
authors.lastname: Aussel
authors.forename: R
authors.initials: R
authors.lastname: Marhaba
authors.forename: C
authors.initials: C
authors.lastname: Pelassy
authors.forename: J P
authors.initials: JP
authors.lastname: Breittmayer
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology; D015703:Antigens, CD / Q000378:metabolism*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000378:metabolism*; D017252:CD3 Complex; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D015220:Calcium Channels / Q000187:drug effects* / Q000378:metabolism; D002460:Cell Line; D003600:Cytosol / Q000378:metabolism; D006801:Humans; D007811:Lanthanum / Q000008:administration & dosage / Q000494:pharmacology*; D037181:Lectins, C-Type; D008213:Lymphocyte Activation / Q000187:drug effects; D008345:Manganese / Q000378:metabolism; D015375:Receptors, Interleukin-2 / Q000378:metabolism*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D013729:Terpenes / Q000494:pharmacology; D019284:Thapsigargin; D000099192:CD69 Antigens
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D002118:Calcium; D002121:Calcium Channel Blockers; D015220:Calcium Channels; D007811:Lanthanum; D037181:Lectins, C-Type; D008345:Manganese; D015375:Receptors, Interleukin-2; D013729:Terpenes; D019284:Thapsigargin; D000099192:CD69 Antigens